{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:38:03Z","timestamp":1772825883929,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:00:00Z","timestamp":1540771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12350-018-01477-y","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T11:33:43Z","timestamp":1540812823000},"page":"1774-1784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Imaging cardiac innervation in hereditary transthyretin (ATTRm) amyloidosis: A marker for neuropathy or cardiomyopathy in case of heart failure?"],"prefix":"10.1016","volume":"27","author":[{"given":"Daphne L.","family":"Jonker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bouke P.C.","family":"Hazenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans L.A.","family":"Nienhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riemer H.J.A.","family":"Slart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andor W.J.M.","family":"Glaudemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Noordzij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1007\/s12350-018-01477-y_bib1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1007\/s12350-018-01477-y_bib2","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jcmg.2016.08.003","article-title":"Cardiac dysautonomia and surviva in hereditary transthyretin amyloidosis","volume":"9","author":"Goldstein","year":"2016","journal-title":"J Am Coll Cardiol Imaging"},{"issue":"4","key":"10.1007\/s12350-018-01477-y_bib3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mus.20821","article-title":"The molecular biology and clinical features of amyloid neuropathy","volume":"36","author":"Benson","year":"2007","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1007\/s12350-018-01477-y_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11912-017-0607-4","article-title":"Cardiac amyloidosis: Diagnosis and treatment strategies","volume":"19","author":"Tuzovic","year":"2017","journal-title":"Curr Oncol Rep."},{"key":"10.1007\/s12350-018-01477-y_bib5","first-page":"1805","article-title":"Amyloidosis and the heart","volume":"166","author":"Shah","year":"2006","journal-title":"Amyloid Int J Exp Clin Investig"},{"issue":"10","key":"10.1007\/s12350-018-01477-y_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11886-017-0911-5","article-title":"Transthyretin cardiac amyloidosis","volume":"19","author":"Mankad","year":"2017","journal-title":"Curr Cardiol Rep"},{"issue":"10","key":"10.1007\/s12350-018-01477-y_bib7","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"Ruberg","year":"2012","journal-title":"Circulation"},{"issue":"1","key":"10.1007\/s12350-018-01477-y_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12350-013-9803-2","article-title":"Nuclear imaging modalities for cardiac amyloidosis","volume":"21","author":"Bokhari","year":"2014","journal-title":"J Nucl Cardiol."},{"issue":"19","key":"10.1007\/s12350-018-01477-y_bib9","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.107.186093","article-title":"The role of endomyocardial biopsy in the management of cardiovascular disease: A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology","volume":"116","author":"Cooper","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1007\/s12350-018-01477-y_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.amjcard.2017.09.029","article-title":"Frequency of and prognostic significance of cardiac involvement at presentation in hereditary transthyretin-derived amyloidosis and the value of N-terminal Pro-B-type natriuretic peptide","volume":"121","author":"Klaassen","year":"2017","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1007\/s12350-018-01477-y_bib11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/13506129.2013.825240","article-title":"Role of natriuretic peptide to predict cardiac abnormalities in patients with hereditary transthyretin amyloidosis","volume":"20","author":"Damy","year":"2013","journal-title":"Amyloid"},{"issue":"3","key":"10.1007\/s12350-018-01477-y_bib12","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2796.2007.01888.x","article-title":"Do troponin and B-natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis?","volume":"263","author":"Suhr","year":"2008","journal-title":"J Intern Med"},{"issue":"6346","key":"10.1007\/s12350-018-01477-y_bib13","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/bmj.285.6346.916","article-title":"Diagnosis and management of diabetic autonomic neuropathy","volume":"285","author":"Ewing","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1007\/s12350-018-01477-y_bib14","series-title":"Cardiovascular autonomic function tests: Methodological considerations and clinical application","first-page":"10","article-title":"Cardiovascular tests","author":"Oei-Reyners","year":"2002"},{"issue":"27","key":"10.1007\/s12350-018-01477-y_bib15","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1007\/s12350-018-01477-y_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"99 mTc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"10.1007\/s12350-018-01477-y_bib17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/13506129.2015.1072089","article-title":"Usefulness of 99m Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis","volume":"22","author":"Galat","year":"2015","journal-title":"Amyloid"},{"issue":"1","key":"10.1007\/s12350-018-01477-y_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/13506129.2013.871250","article-title":"Bone scintigraphy with 99m-technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis","volume":"6129","author":"Glaudemans","year":"2014","journal-title":"Amyloid"},{"issue":"6","key":"10.1007\/s12350-018-01477-y_bib19","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1007\/s12350-018-01477-y_bib20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","article-title":"Role of 99mTc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis","volume":"4","author":"Rapezzi","year":"2011","journal-title":"J Am Coll Cardiol Imaging"},{"issue":"24","key":"10.1007\/s12350-018-01477-y_bib21","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"issue":"4","key":"10.1007\/s12350-018-01477-y_bib22","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3109\/13506129.2012.717993","article-title":"Clinical use of differential nuclear medicine modalities in patients with ATTR amyloidosis","volume":"19","author":"Noordzij","year":"2012","journal-title":"Amyloid"},{"issue":"5","key":"10.1007\/s12350-018-01477-y_bib23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.carpath.2016.07.001","article-title":"Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis","volume":"25","author":"Stats","year":"2016","journal-title":"Cardiovasc Pathol"},{"key":"10.1007\/s12350-018-01477-y_bib24","series-title":"Autonomic innervation of the heart: role of moleculare imaging","first-page":"321","article-title":"Nuclear imaging of the autonomic nervous system in cardiac amyloidosis","author":"Noordzij","year":"2015"},{"key":"10.1007\/s12350-018-01477-y_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10741-014-9463-6","article-title":"Nuclear imaging for cardiac amyloidosis","volume":"20","author":"Noordzij","year":"2015","journal-title":"Heart Fail Rev"},{"issue":"1","key":"10.1007\/s12350-018-01477-y_bib26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0735-1097(96)00438-X","article-title":"Iodine-123 metaiodobenzylguanidine scintigraphic assessment of myocardial sympathetic innervation in patients with familial amyloid polyneuropathy","volume":"29","author":"Tanaka","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-018-01477-y_bib27","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00259-012-2187-8","article-title":"I-Labelled metaiodobenzylguanidine for the evaluation of cardiac sympathetic denervation in early stage amyloidosis","volume":"39","author":"Noordzij","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1007\/s12350-018-01477-y_bib28","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s002590050406","article-title":"Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability","volume":"26","author":"Delahaye","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"10.1007\/s12350-018-01477-y_bib29","article-title":"Imaging cardiac innervation in amyloidosis","author":"Slart","year":"2017","journal-title":"J Nucl Cardiol"},{"issue":"6","key":"10.1007\/s12350-018-01477-y_bib30","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0002-9440(10)63050-7","article-title":"Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: Evidence for toxicity of nonfibrillar aggregates","volume":"159","author":"Sousa","year":"2001","journal-title":"Am J Pathol"},{"issue":"9","key":"10.1007\/s12350-018-01477-y_bib31","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s00259-010-1491-4","article-title":"Proposal for standardization of123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology","volume":"37","author":"Flotats","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-018-01477-y_bib32","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s12350-014-9916-2","article-title":"Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations","volume":"21","author":"Nakajima","year":"2014","journal-title":"J Nucl Cardiol"},{"issue":"5","key":"10.1007\/s12350-018-01477-y_bib33","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s12350-016-0546-8","article-title":"Correction of collimator-dependent differences in the heart-to-mediastinum ratio in123I-metaiodobenzylguanidine cardiac sympathetic imaging: Determination of conversion equations using point-source imaging","volume":"24","author":"Inoue","year":"2017","journal-title":"J Nucl Cardiol"},{"issue":"11","key":"10.1007\/s12350-018-01477-y_bib34","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.4065\/83.11.1226","article-title":"Patterns of neuropathy and autonomic failure in patients with amyloidosis","volume":"83","author":"Wang","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1007\/s12350-018-01477-y_bib35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajh.20381","article-title":"Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis","volume":"79","author":"Gertz","year":"2005","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1007\/s12350-018-01477-y_bib36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.pcad.2009.11.007","article-title":"Amyloid heart disease","volume":"52","author":"Falk","year":"2010","journal-title":"Prog Cardiovasc Dis"},{"issue":"1","key":"10.1007\/s12350-018-01477-y_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tcm.2017.07.004","article-title":"Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment","volume":"28","author":"Siddiqi","year":"2017","journal-title":"Trends Cardiovasc Med"},{"issue":"21","key":"10.1007\/s12350-018-01477-y_bib38","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1136\/heartjnl-2012-301924","article-title":"Cardiac transthyretin amyloidosis","volume":"98","author":"Dungu","year":"2012","journal-title":"Heart"},{"issue":"2","key":"10.1007\/s12350-018-01477-y_bib39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10741-015-9480-0","article-title":"Cardiac amyloidosis: The great pretender","volume":"20","author":"Rapezzi","year":"2015","journal-title":"Heart Fail Rev"},{"issue":"12","key":"10.1007\/s12350-018-01477-y_bib40","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.jcmg.2016.07.008","article-title":"Cardiac dysautonomia predicts long-term survival in hereditary transthyretin amyloidosis after liver transplantation","volume":"9","author":"Algalarrondo","year":"2016","journal-title":"J Am Coll Cardiol Imaging"},{"issue":"24","key":"10.1007\/s12350-018-01477-y_bib41","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1161\/hc4901.100380","article-title":"Myocardial muscarinic receptor upregulation and normal response to isoproterenol in denervated hearts by familial amyloid polyneuropathy","volume":"104","author":"Delahaye","year":"2001","journal-title":"Circulation"},{"issue":"7","key":"10.1007\/s12350-018-01477-y_bib42","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1007\/s00259-018-3963-x","article-title":"Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriers","volume":"45","author":"Piekarski","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1007\/s12350-018-01477-y_bib43","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/CIRCIMAGING.112.000367","article-title":"Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy","volume":"6","author":"Coutinho","year":"2013","journal-title":"Circ Cardiovasc Imaging"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-018-01477-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12350-018-01477-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123020056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123020056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-018-01477-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:07:03Z","timestamp":1761026823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123020056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1071358123020056"],"URL":"https:\/\/doi.org\/10.1007\/s12350-018-01477-y","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging cardiac innervation in hereditary transthyretin (ATTRm) amyloidosis: A marker for neuropathy or cardiomyopathy in case of heart failure?","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-018-01477-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}